Ad Platforms Are Closing on GLP-1. AI Search Isn't.
Google and Meta are progressively restricting GLP-1, compounded semaglutide, and weight loss telehealth advertising. Meanwhile prospects spend 3-8 weeks asking ChatGPT and Perplexity "best GLP-1 telehealth," "legit compounded semaglutide," and "Wegovy vs Zepbound insurance coverage" before they convert. We get your weight loss / GLP-1 program cited where the entire research journey happens — backed by OMA, ASMBS, and FDA-aligned authority signals.
See how many leads you can generate with AI.
Where GLP-1 Prospects Actually Research — For Weeks Before They Convert
The GLP-1 buying journey isn't a click — it's a 3-8 week research arc across ChatGPT, Perplexity, Reddit, and Google AI. The brand cited across that arc wins the conversion.
"Best GLP-1 Telehealth" Brand Shortlists
Hims, Ro, Found, Calibrate, Sequence, Noom — every category leader is now competing for AI brand-name citations. "Best GLP-1 telehealth 2026," "cheapest legit semaglutide," "compounded vs branded GLP-1." These are the shortlist queries where conversions are won.
FDA + PI Compliance Audits in AI
Prospects ask AI assistants "is [brand] FDA-compliant," "is [brand] using 503A pharmacy," "what are Wegovy side effects." AI's answer is sourced from FDA Compounding guidance and PI labels — we ensure your brand surfaces favorably.
Insurance, Cost & Coverage Questions
"GLP-1 covered by Aetna 2026," "compounded semaglutide cost vs Wegovy," "Zepbound prior authorization help." Insurance and cost queries are the highest-intent layer of the GLP-1 funnel — and AI is the dominant research channel.
See How It Works
Watch how Snezzi gets regulated DTC health brands cited in AI search
From Invisible to Cited — Here's How
A clear path from $400-$900 paid GLP-1 CACs to becoming the brand AI shortlists
Audit Your GLP-1 Brand's AI Presence
We benchmark which GLP-1 telehealth brands AI assistants cite for your top category queries — Hims, Ro, Found, Sequence, Calibrate, and rising compound programs. You'll see exactly who's in the shortlist your prospects see.
Map FDA / FTC-Safe GLP-1 Queries
We identify revenue-driving queries within FDA Compounding and FTC Telehealth guidance. PI-aligned, side-effect transparent, off-label-free.
Build OMA / ASMBS-Aligned Authority
We engineer the prescriber credentialing, OMA / ASMBS-aligned protocol transparency, 503A/503B compounding compliance, and citation-grade content AI models use to decide which GLP-1 program to recommend.
Track, Iterate, Compound
Snezzi's tracker monitors GLP-1 AI citations weekly across ChatGPT, Perplexity, Reddit AI, and Google AI Overviews. Iterate against gaps. The 3-8 week GLP-1 research journey means citations compound enormously vs. paid attribution.
GLP-1-Specific AI SEO — What's Included
Brand Brain + 6 AI agents tuned for GLP-1 telehealth, compounded semaglutide, and weight loss DTC category economics
GLP-1 Brand Brain
Prescriber credentialing, 503A/503B pharmacy partners, dosing protocols, side-effect monitoring, insurance navigation, and OMA/ASMBS-aligned program structure encoded as a structured knowledge graph AI assistants ingest and cite.
Compliance-Safe Answer-First Content
Citation-grade content for "best GLP-1 telehealth," "compounded semaglutide programs," "Wegovy vs Zepbound." Every claim grounded in FDA labels, peer-reviewed clinical evidence, and OMA/ASMBS protocol guidance.
Authority Backlinks From Clinical Publications
Our Backlink Agent secures placements on the obesity medicine, endocrinology, and metabolic health publications AI models trust — the actual citation sources behind ChatGPT and Perplexity GLP-1 recommendations.
Regulated DTC Health Brands We've Worked With
We're being honest — these aren't GLP-1 telehealth case studies. They're our closest analogues: regulated DTC health brands where ad platforms restricted growth and AI search opened it back up.
See detailed breakdowns of how these regulated brands achieved results
View Full Case StudiesWhat Regulated DTC Health Founders Say
"Working with Snezzi has been a game changer for us. Before using it, most of our traffic came from random sources and running ads was nearly impossible in our category. After implementing Snezzi's recommendations and insights, our organic visibility and orders grew steadily month after month. The team helped us refine our website, content, and structure in a way that actually drives results. It's rare to find a partner that understands both SEO and the realities of regulated markets so well."
"We were spending heavily on Instagram and Google ads with diminishing returns. Snezzi helped us build a presence in AI search that we didn't even know existed. Within a few months, customers were finding us through ChatGPT and Perplexity recommendations instead of ads. Our CAC dropped significantly and the traffic keeps compounding. It's the best investment we've made for sustainable growth."
Related Health & Wellness Specializations
GLP-1 / weight loss is one of 10 health & wellness categories we serve.
Functional Medicine & Metabolic Health
For brands at the intersection of weight loss, hormone optimization, and lifestyle medicine. Many GLP-1 programs benefit from the functional medicine playbook overlay.
Fertility & Women's Health
PCOS-driven weight loss, perimenopause hormone optimization, and fertility-adjacent metabolic programs share the same regulated-telehealth authority playbook.
All Health & Wellness Verticals
Hub mapping all 10 DTC and practice categories — supplements, pet wellness, botanicals, skincare, functional medicine, fertility, and clinical practices.
Frequently Asked Questions
Yes. Google and Meta are progressively restricting GLP-1 advertising — compounded semaglutide ads, off-label claims, and aggressive cost-comparison creative all face increasing scrutiny. ChatGPT, Perplexity, and Google AI have no equivalent ad policy. When a prospect asks 'legit compounded semaglutide telehealth' or 'best GLP-1 program with insurance,' the answer is built from FDA-cited content, prescriber credentials, and citation-grade authority — exactly what we engineer.
Significantly longer than supplements. Prospects research GLP-1 telehealth for 3-8 weeks before converting — they're comparing prescriber states, compound pharmacies, dosing protocols, insurance coverage, and side-effect profiles. AI assistants are now the primary research substrate. Brands cited in ChatGPT and Perplexity for 'best GLP-1 telehealth 2026' compound trust across that entire 3-8 week window.
We follow <a href='https://www.fda.gov/drugs/human-drug-compounding/compounding-and-drug-shortages'>FDA Compounding</a> guidance, FDA's <a href='https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s011lbl.pdf'>Wegovy</a> and <a href='https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209637s032lbl.pdf'>Ozempic</a> labels line by line, and <a href='https://www.ftc.gov/business-guidance/resources/telehealth-advertising-frequently-asked-questions'>FTC Telehealth Advertising</a> guidance. Structure/function claims and PI-aligned content only — no off-label, no aggressive comparison claims, no manufactured testimonials.
Yes — but the playbook differs. Branded GLP-1 programs lean on insurance navigation content, in-network prescriber networks, and PA workflow authority. Compounded programs lean on 503A/503B pharmacy compliance, dosing protocol transparency, and prescriber credentialing. Both win in AI search through OMA (<a href='https://obesitymedicine.org/'>Obesity Medicine Association</a>) and ASMBS (<a href='https://asmbs.org/'>American Society for Metabolic and Bariatric Surgery</a>)-aligned authority.
We're being honest — GLP-1 telehealth is an emerging vertical for our agency. Our closest analogues are regulated DTC health brands: Herbal Supplements (3X AI mentions, 300% traffic, 10+ monthly orders in 4 months) and a DTC skincare brand (4X AI mentions, 150% traffic, 35% lower CAC in 3 months). The compliance and citation-grade content playbook translates directly to GLP-1 telehealth — that's the work we're already doing.
Our plans are a small fraction of a single month of Hims / Ro / Found-scale paid GLP-1 budget. GLP-1 CACs from paid currently sit in the $400-$900 range across most operators; AI citations have effectively zero marginal cost once your brand is cited. The ratio gets better every quarter as paid CACs continue to inflate.
Yes. ChatGPT and Perplexity are global; AI shortlists are increasingly market-specific. We adapt to MHRA / Health Canada / DCGI regulatory frameworks while keeping the citation playbook consistent. Authority sources change (NICE, Health Canada Drug Product Database, CDC ART) but the citation architecture stays the same.
30 minutes with our founders. We benchmark exactly which GLP-1 telehealth or weight-loss competitors AI assistants cite for your category queries, score your AI visibility, and hand you a prioritized 90-day roadmap. No obligation.
Generate Leads Now
30 minutes with our founders. We'll show you exactly which GLP-1 telehealth competitors are winning AI shortlists — and the 90-day roadmap to displace them. No obligation.
